Data as of 10:41am ET
| +0.11 / +1.84%|
The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +145.90% increase from the last price of 6.10.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.